Announcements Trials

Browse Landscape

Phase

Status

Recruiting 6 Not yet recruiting 3 Completed 1 Active not recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 1

Interventions

pembrolizumab 224 Cyclophosphamide 192 Radiotherapy 183 Nivolumab 180 Carboplatin 153 Cisplatin 114 Paclitaxel 112 Dexamethasone 110 Radiosurgery 104 Magnetic Resonance Spectroscopy 97 Surveys and Questionnaires 91 Ipilimumab 81 Doxorubicin 79 Lenalidomide 76 durvalumab 75 Rituximab 75 atezolizumab 72 Radiation 72 venetoclax 69 fludarabine 68 Standard of Care 68 Gemcitabine 68 Specimen Handling 65 Etoposide 64 Capecitabine 64 Bevacizumab 62 Oxaliplatin 59 Docetaxel 58 Biopsy 58 Radiotherapy, Intensity-Modulated 56

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × OTHER × axatilimab × Clear all

NCT05723055 2026-05-08

NAHL

University of Utah

Phase 2 Active not recruiting

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡